Becton Dickinson & Co
Close on Oct 19, 2026Market cap $52.48BP/E 57.6Yield 2.18%
Becton Dickinson Cumulative Registered Clinical Studies by Year
Cumulative Registered Clinical Studies — BD & C.R. Bard
Becton Dickinson Cumulative Registered Clinical Studies: 90 in FY2026, up 12.5% from a year earlier. That is the highest of the 12 years on record here.
Where the FY2026 figure comes from
Source: NIH ClinicalTrials.gov Registry — Becton Dickinson & C.R. Bard ↗
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Becton Dickinson Cumulative Registered Clinical Studies, annual FY2015–FY2026 [Data set]. Compiled from Becton Dickinson SEC filings and investor materials. https://stockdatahq.com/stocks/bdx/kpis/ext-ct-cum
See every metric in the Becton Dickinson KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?